Shanghai University of Traditional Chinese Medicine clinical trials
Shanghai University of Traditional Chinese Medicine is the lead sponsor of 10 current clinical trials in our China and Japan registers. 7 are recruiting patients now. The most common phase is Not applicable. The most-studied condition is Primary Osteoporosis.
ClinicalTrials.gov trials by status
Trials by phase
Clinical trials sponsored by Shanghai University of Traditional Chinese Medicine
10 on ClinicalTrials.gov| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
TCM as an Adjuvant Treatment in Mycobacterium Abscessus Pulmonary Disease
NCT07295938 · ClinicalTrials.gov ↗ · Mycobacterium Abscessus Pulmonary Disease
|
Phase 2 | Recruiting | 2025-09 | China, Japan |
|
Baduanjin Training for Depression and Anxiety Patients
NCT05589337 · ClinicalTrials.gov ↗ · Depression Symptoms, Anxiety Symptoms
|
Not applicable | Recruiting | 2021-07 | China |
|
TCM Daoyin for Anxiety/Depression: Psychological Effects and Biological Mechanisms
NCT06921512 · ClinicalTrials.gov ↗ · Anxiety Symptom, Depression Symptom
|
Not applicable | Recruiting | 2025-04 | China |
|
Clinical Study on the Prevention of Driver Gene Negative Ib-IIIb Lung Cancer Recurrence and Metastasis by Staged Chinese Herbal Medicine Combined With Chemotherapy and Immune Checkpoint Inhibitors
NCT05834413 · ClinicalTrials.gov ↗ · Lung Cancer
|
Not applicable | Recruiting | 2023-05 | China |
|
Multicenter Cohort Study on Osteoporosis
NCT02958020 · ClinicalTrials.gov ↗ · Osteoporosis
|
Observational | Recruiting | 2016-11 | China |
|
The Association of Transgelin-2, Metallothionein-2 and Ezrin With Asthma
NCT05496582 · ClinicalTrials.gov ↗ · Asthma
|
Observational | Recruiting | 2022-11 | China |
|
A Study on the Treatment of Patients With Acute Lung Injury Caused by Sepsis Through Microbiota Transplantation
NCT07342205 · ClinicalTrials.gov ↗ · Acute Respiratory Distress Syndrome (ARDS), Acute Lung Injury(ALI), Sepsis Related Acute Lung Injury/Acute Respiratory Distress Syndrome
|
Phase 2/3 | Recruiting | 2025-12 | China |
|
EOCRCPred: an AI Model to Predict Survival in EOCRC Patients After Surgery
NCT06690606 · Colorectal Cancer
|
Observational | Not yet open | 2024-11 | China |
|
Quanduzhong Capsules for Primary Osteoporosis
NCT07895082 · ClinicalTrials.gov ↗ · Primary Osteoporosis
|
Phase 3 | By invitation | 2026-10 | China |
|
TCM Daoyin Therapy in Individuals At-risk for COPD
NCT05940480 · ClinicalTrials.gov ↗ · Chronic Obstructive Pulmonary Disease, Lung Diseases, Obstructive
|
Not applicable | Active, closed | 2023-01 | China |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
Conditions in Shanghai University of Traditional Chinese Medicine trials
15 conditionsBy trial register
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in China | 10 | 7 |
| Clinical trials in Japan | 1 | 1 |
A trial with sites in more than one country appears in each of those registers.
Questions about Shanghai University of Traditional Chinese Medicine trials
How many clinical trials does Shanghai University of Traditional Chinese Medicine sponsor?
Shanghai University of Traditional Chinese Medicine is the lead sponsor of 10 current trials on ClinicalTrials.gov in our China and Japan registers, as of the registry sync on 10 November 2026. Completed and withdrawn studies are not counted.
Are Shanghai University of Traditional Chinese Medicine trials recruiting?
Yes. 7 of its 10 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Where does this information come from?
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
How this page is built
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
- EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 10 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.